Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population
- PMID: 20444451
- PMCID: PMC2914160
- DOI: 10.1016/j.atherosclerosis.2010.03.021
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population
Abstract
Objectives: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and lipoprotein(a) [Lp(a)] have been implicated as cardiovascular disease risk factors, and are differentially regulated across ethnicity. We investigated the association between Lp-PLA(2) activity and allele-specific apolipoprotein(a) [apo(a)] levels in a bi-ethnic population.
Methods: Lp-PLA(2) activity, Lp(a) and allele-specific apo(a) levels were determined in 224 African Americans and 336 Caucasians.
Results: Lp-PLA(2) activity level was higher among Caucasians compared to African Americans (173 + or - 41 nmol/min/ml vs. 141 + or - 39 nmol/min/ml, P<0.001), and positively associated with Lp(a), total and LDL cholesterol, triglyceride, apolipoprotein B-100, and negatively with HDL cholesterol levels in both ethnic groups. The association between Lp-PLA(2) activity and Lp(a) was stronger among African Americans compared to Caucasians (R=0.238, beta(1)=3.48, vs. R=0.111, beta(1)=1.93, respectively). The Lp-PLA(2) activity level was significantly associated with allele-specific apo(a) levels for smaller (<26 K4 repeats) apo(a) sizes in both ethnic groups (P=0.015 for African Americans, P=0.038 for Caucasians). In contrast, for larger (>26 K4 repeats) apo(a) sizes, high Lp-PLA(2) activity levels were associated with higher allele-specific apo(a) levels in African Americans (P=0.009), but not in Caucasians.
Conclusion: The association between Lp-PLA(2) activity and allele-specific apo(a) levels differs across African American-Caucasian ethnicity.
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Figures



Similar articles
-
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.Atherosclerosis. 2014 Jul;235(1):223-9. doi: 10.1016/j.atherosclerosis.2014.04.035. Epub 2014 May 10. Atherosclerosis. 2014. PMID: 24859635 Free PMC article.
-
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.Transl Res. 2011 Aug;158(2):92-8. doi: 10.1016/j.trsl.2011.01.004. Epub 2011 Feb 5. Transl Res. 2011. PMID: 21757153 Free PMC article.
-
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1. J Clin Endocrinol Metab. 2010. PMID: 20194707 Free PMC article.
-
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.J Lipid Res. 2002 Feb;43(2):234-44. J Lipid Res. 2002. PMID: 11861665
-
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.J Clin Endocrinol Metab. 2008 Apr;93(4):1482-8. doi: 10.1210/jc.2007-2416. Epub 2008 Feb 5. J Clin Endocrinol Metab. 2008. PMID: 18252779 Free PMC article.
Cited by
-
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):387-92. doi: 10.1161/ATVBAHA.112.300125. Epub 2012 Nov 29. Arterioscler Thromb Vasc Biol. 2013. PMID: 23202367 Free PMC article.
-
Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.Metab Syndr Relat Disord. 2011 Dec;9(6):411-8. doi: 10.1089/met.2011.0026. Epub 2011 Jul 12. Metab Syndr Relat Disord. 2011. PMID: 21749171 Free PMC article. Review.
-
Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study.J Lipid Res. 2018 Oct;59(10):1967-1976. doi: 10.1194/jlr.P084517. Epub 2018 Jul 16. J Lipid Res. 2018. PMID: 30012717 Free PMC article.
-
Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A2 and C-reactive protein: a cross-sectional study.Eur J Nutr. 2024 Mar;63(2):445-460. doi: 10.1007/s00394-023-03277-8. Epub 2023 Dec 8. Eur J Nutr. 2024. PMID: 38063929 Free PMC article.
-
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.Atherosclerosis. 2012 Jul;223(1):230-4. doi: 10.1016/j.atherosclerosis.2012.04.021. Epub 2012 May 8. Atherosclerosis. 2012. PMID: 22632920 Free PMC article.
References
-
- Ballantyne C, Cushman M, Psaty B, et al. Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil. 2007;14:3–11. - PubMed
-
- Garza CA, Montori VM, McConnell JP, et al. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc. 2007;82:159–165. - PubMed
-
- Tselepis AD, Dentan C, Karabina SA, et al. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arteriosclerosis, thrombosis, and vascular biology. 1995;15:1764–1773. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous